CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSION
- 1 July 1980
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 316 (8186) , 108-110
- https://doi.org/10.1016/s0140-6736(80)90002-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- CAPTOPRIL: REVERSIBLE RENAL FAILURE WITH SEVERE HYPERKALÆMIAThe Lancet, 1980
- Response of Arterial Blood Pressure, Plasma Renin Activity and Plasma Aldosterone Concentration to Long-Term Administration of Captopril in Patients with Severe, Treatment-Resistant Malignant HypertensionClinical Science, 1979
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- MINOXIDIL IN RESISTANT HYPERTENSIONThe Lancet, 1977
- Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic BlockadeNew England Journal of Medicine, 1972
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972